Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Cellular Biochemistry
|
July 23, 2021
The role of Bag3 in cell signaling
Michael Y Sherman, Vladimir Gabai
Molecular and Cellular Biology
|
May 16, 2003
Inactivation of dual-specificity phosphatases is involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp72
Julia Yaglom, Cornelia O'Callaghan-Sunol, Vladimir Gabai, et al.
FEBS Letters
|
June 9, 2007
Molecular chaperones regulate p53 and suppress senescence programs
Michael Y Sherman, Michael Sherman, Vladimir Gabai, et al.
General and Comparative Endocrinology
|
March 1, 2022
P62/SQSTM1 enhances osteogenesis and attenuates inflammatory signals in bone marrow microenvironment
Dimitrios Agas, Vladimir Gabai, Albert A Sufianov, et al.
Journal of Cellular Physiology
|
December 24, 2022
p62/SQSTM1 indirectly mediates remote multipotent mesenchymal cells and rescues bone loss and bone marrow integrity in ovariectomized rats
Dimitrios Agas, Andrea Marchegiani, Fulvio Laus, et al.
Plos One
|
January 17, 2008
Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency
Petr O Ilyinskii, Alexandra S Gambaryan, Anatoli B Meriin, et al.
Aging
|
November 23, 2019
p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity
Franco M Venanzi, Vladimir Gabai, Francesca Mariotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 23, 2026
Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial
Sergei Krasny, Yauheni Baranau, Evgeny Bakin, et al.
Frontiers in Oncology
|
February 27, 2024
Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial
Sergei Krasny, Yauheni Baranau, Sergey Polyakov, et al.
The Journal of Biological Chemistry
|
January 13, 2006
Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation
Kathleen Ruchalski, Haiping Mao, Zhijian Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Cellular Biochemistry
|
July 23, 2021
The role of Bag3 in cell signaling
Michael Y Sherman, Vladimir Gabai
Molecular and Cellular Biology
|
May 16, 2003
Inactivation of dual-specificity phosphatases is involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp72
Julia Yaglom, Cornelia O'Callaghan-Sunol, Vladimir Gabai, et al.
FEBS Letters
|
June 9, 2007
Molecular chaperones regulate p53 and suppress senescence programs
Michael Y Sherman, Michael Sherman, Vladimir Gabai, et al.
General and Comparative Endocrinology
|
March 1, 2022
P62/SQSTM1 enhances osteogenesis and attenuates inflammatory signals in bone marrow microenvironment
Dimitrios Agas, Vladimir Gabai, Albert A Sufianov, et al.
Journal of Cellular Physiology
|
December 24, 2022
p62/SQSTM1 indirectly mediates remote multipotent mesenchymal cells and rescues bone loss and bone marrow integrity in ovariectomized rats
Dimitrios Agas, Andrea Marchegiani, Fulvio Laus, et al.
Plos One
|
January 17, 2008
Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency
Petr O Ilyinskii, Alexandra S Gambaryan, Anatoli B Meriin, et al.
Aging
|
November 23, 2019
p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity
Franco M Venanzi, Vladimir Gabai, Francesca Mariotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 23, 2026
Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial
Sergei Krasny, Yauheni Baranau, Evgeny Bakin, et al.
Frontiers in Oncology
|
February 27, 2024
Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial
Sergei Krasny, Yauheni Baranau, Sergey Polyakov, et al.
The Journal of Biological Chemistry
|
January 13, 2006
Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation
Kathleen Ruchalski, Haiping Mao, Zhijian Li, et al.
Page
of 2